Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
NovaSight is a cutting-edge ophthalmic medical device company dedicated to transforming children's vision care. They develop and commercialize innovative, AI-driven eye-tracking based solutions aimed at early diagnosis and treatment of vision disorders, with a primary focus on amblyopia (lazy eye) and myopia. Their flagship products, such as CureSight™ for amblyopia treatment and EyeSwift® PRO for vision assessment, leverage advanced technology to provide engaging, effective, and accessible care for young patients, aiming to prevent long-term vision impairment.
Serves as the central hub for research and development, product innovation, corporate strategy, global operations management, and administrative functions.
Located in a modern business park with access to advanced infrastructure, fostering collaboration and innovation in the medical technology sector. Proximity to an international airport facilitates global business operations.
A dynamic, collaborative, and innovative environment focused on research excellence, patient impact, and technological advancement. Emphasizes a mission-driven approach to improving children's vision and quality of life.
The headquarters is pivotal for NovaSight's mission, housing the core R&D teams that develop its groundbreaking eye-tracking and AI-based vision care solutions. Its location in Israel's vibrant tech hub facilitates access to top talent and strategic partnerships.
NovaSight operates with a global vision, spearheaded by its R&D and strategic hub in Israel and complemented by a growing commercial presence in key international markets, most notably the United States. The company is actively expanding its reach through strategic partnerships and distribution networks to make its innovative pediatric vision care solutions, such as CureSight™ for amblyopia and EyeSwift® PRO for vision assessment, accessible to children worldwide. Its products are designed to meet diverse international regulatory standards, facilitating global market entry.
Building C, Northern Industrial Park
Airport City
Central District
Israel
Address: 40 W Park Pl, Morristown, NJ 07960 (Note: This address is based on public directory information and may represent a registered agent or commercial office. Verify for specific operational functions.)
To drive the adoption and sales of NovaSight's pediatric vision care solutions within the United States, manage relationships with U.S. healthcare providers and distributors, and navigate the local regulatory and market landscape.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, NovaSight' leadership includes:
NovaSight has been backed by several prominent investors over the years, including:
NovaSight strengthened its executive leadership in the past 12 months with the key appointment of Liran Adlin as Chief Financial Officer in November 2023. This move aims to bolster the company's financial strategy and execution during its ongoing commercial expansion and growth phase. No major executive departures have been publicly announced during this period.
Discover the tools NovaSight uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
NovaSight likely utilizes standard professional email formats for its employees. Based on publicly available contact information, one commonly observed format appears to be [first name]@[companydomain.com]. Other formats such as [first initial][last name]@[companydomain.com] or [first name].[last name]@[companydomain.com] may also be in use.
[first]@novasight.com
Format
lena@novasight.com
Example
75%
Success rate
PR Newswire • April 29, 2024
NovaSight announced its participation in the American Pediatric Association (APA) 2024 meeting, where it showcased its portfolio of AI-powered vision care solutions. These include the CureSight™ amblyopia treatment and EyeSwift® PRO vision assessment system, underscoring the company's commitment to advancing pediatric eye care through innovative technology....more
Eyewire News • February 13, 2024
NovaSight announced it has received CE Mark approval in Europe for its CureSight™ system, an eye-tracking based digital therapy for amblyopia (lazy eye). This significant milestone allows NovaSight to commercialize CureSight™ across European Union member states and other CE Mark-recognizing countries, expanding access to its innovative home-based treatment for children....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including NovaSight, are just a search away.